TrialSignal
Clinical trial intelligence report
A Pilot Study to Examine Deep Brain Stimulation (DBS) in the Basolateral Nucleus (BLn) of the Amygdala for the Management of Symptoms in Veterans With Chronic and Treatment-Refractory Combat-related Post-Traumatic Stress Disorder (PTSD)
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT01658748
Status
WITHDRAWN
Phase
Withdrawn
Sponsor
US Department of Veterans Affairs
Executive brief
Investment-Ready Snapshot
This pilot study aimed to evaluate the safety and efficacy of deep brain stimulation (DBS) targeting the basolateral nucleus of the amygdala in veterans with treatment-refractory PTSD. The study was sponsored by the US Department of Veterans Affairs and intended to recruit combat veterans suffering from severe PTSD symptoms despite existing treatment options.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01658748
Indication
Post Traumatic Stress Disorder
Modality
gene therapy
Target
Post-Traumatic Stress Disorder (PTSD)
Intervention
Week 0 Medtronic 3387 electrodes/Activa PC amygdala DBS, Week 12 Medtronic 3387 electrodes/Activa PC amygdala DBS
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.